glp-1 기전 기반 차세대 항당뇨병제는 누구? < 내분비/신장 < 학술 < 기사본문 인크레틴" 기반의 이상적인 당뇨병 치료제

NICE guidance recommends annual diabetic eye screening for all people with diabetes, with the frequency of ophthalmological review potentially adjusted based on individual clinical factors such as existing retinopathy and anticipated speed of glycaemic improvement

Among GLP1-RA users, 6727 (24.9%) initially used DPP4i before switching to GLP1-RA

GLP-1 + diabetes challenge How this product helps Reduced appetite Convenient meal replacement format Inconsistent food intake Structured daily nutrition with each serve Blood sugar management Low-GI formulation with glucose metabolism support Muscle loss risk High-quality protein per serve Digestive changes Dietary fibre and probiotics

They may also lead to hypoglycemia (low blood sugar), especially in people who take other anti-diabetes medicines

Poor tolerability